These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 22288056)
21. [The treatment of medullary thyroid cancer]. Fujita T; Fujimori M Gan To Kagaku Ryoho; 2009 Oct; 36(10):1627-31. PubMed ID: 19838021 [TBL] [Abstract][Full Text] [Related]
22. Choroidal metastasis as initial presentation of aggressive medullary thyroid carcinoma with widespread mediastinal, brain, pituitary, bone, lung, and liver metastasis: Case report and literature review. Al Hassan MS; El Ansari W; Alater A; Darweesh A; Abdelaal A Int J Surg Case Rep; 2021 Oct; 87():106419. PubMed ID: 34597971 [TBL] [Abstract][Full Text] [Related]
23. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes. Skinner MA; Wells SA Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335 [TBL] [Abstract][Full Text] [Related]
24. Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas. Uchino S; Noguchi S; Adachi M; Sato M; Yamashita H; Watanabe S; Murakami T; Toda M; Murakami N; Yamashita H Jpn J Cancer Res; 1998 Apr; 89(4):411-8. PubMed ID: 9617347 [TBL] [Abstract][Full Text] [Related]
26. [Results of treating medullary thyroid carcinoma: the differences between sporadic and inherited forms]. Wygoda Z; Włoch J; Gubała E; Wiench M; Jarzab B Wiad Lek; 2001; 54 Suppl 1():422-31. PubMed ID: 12182060 [TBL] [Abstract][Full Text] [Related]
27. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma. Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880 [TBL] [Abstract][Full Text] [Related]
28. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience. Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924 [TBL] [Abstract][Full Text] [Related]
29. [Germline mutations of the ret proto-oncogene in Chilean patients with hereditary and sporadic medullary thyroid carcinoma]. Wohllk N; Becker P; Youlton R; Cote GJ; Gagel RF Rev Med Chil; 2001 Jul; 129(7):713-8. PubMed ID: 11552438 [TBL] [Abstract][Full Text] [Related]
30. Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation. Michiels FM; Chappuis S; Caillou B; Pasini A; Talbot M; Monier R; Lenoir GM; Feunteun J; Billaud M Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3330-5. PubMed ID: 9096393 [TBL] [Abstract][Full Text] [Related]
31. Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form. Figlioli G; Landi S; Romei C; Elisei R; Gemignani F Mutat Res; 2013; 752(1):36-44. PubMed ID: 23059849 [TBL] [Abstract][Full Text] [Related]
35. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma. Chiefari E; Russo D; Giuffrida D; Zampa GA; Meringolo D; Arturi F; Chiodini I; Bianchi D; Attard M; Trischitta V; Bruno R; Giannasio P; Pontecorvi A; Filetti S J Endocrinol Invest; 1998 Jun; 21(6):358-64. PubMed ID: 9699127 [TBL] [Abstract][Full Text] [Related]
36. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)". Fink M; Weinhüsel A; Niederle B; Haas OA Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874 [TBL] [Abstract][Full Text] [Related]